Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 4, Number 2—June 1998


Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives

Ashok RattanComments to Author , Awdhesh KaliaComments to Author , and Nishat Ahmad
Author affiliations: All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India

Main Article


Gene loci involved in conferring drug-resistance in Mycobacterium tuberculosis

Drug Gene Product Reported frequency 
in resistant 
strainsa (%) Reference
Rifampicin rpoB B-subunit of RNA polymerase >95 45-48,68-71
Isoniazid katG Catalase-peroxidase 60-70 39-48
oxyR-ahpC Alky hydro-reductase ~20 36
INH-Ethionamide inhA Enoyl-ACP reductase <10 46-48
Streptomycin rpsL Ribosomal protein S12 60 46-48
rrs 16s rRNA <10 113-117
Fluoroquinolone gyrA DNA gyrase >90 107
Pyrazinamide pncA Amidase 70-100 92-94
Ethambutol embCAB EmbCAB 69 88

aMutation frequencies are as determined by sequencing and polymerase chain reaction-single strand conformational polymorphism (PCR-SSCP) analysis.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO